Lifecore Biomedical, Inc.
LFCR
$6.38
$0.213.40%
NASDAQ
| 02/23/2025 | 11/24/2024 | 08/25/2024 | 05/26/2024 | 02/25/2024 | |
|---|---|---|---|---|---|
| Revenue | 130.31M | 130.86M | 128.45M | 128.26M | 121.52M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 130.31M | 130.86M | 128.45M | 128.26M | 121.52M |
| Cost of Revenue | 86.72M | 85.22M | 83.94M | 86.41M | 89.16M |
| Gross Profit | 43.59M | 45.64M | 44.51M | 41.85M | 32.36M |
| SG&A Expenses | 45.32M | 45.07M | 43.54M | 39.25M | 39.32M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 140.35M | 138.74M | 136.09M | 134.24M | 137.02M |
| Operating Income | -10.05M | -7.88M | -7.65M | -5.98M | -15.49M |
| Income Before Tax | -44.70M | -14.92M | 5.78M | 9.51M | -20.11M |
| Income Tax Expenses | -47.00K | 178.00K | 70.00K | 183.00K | 470.00K |
| Earnings from Continuing Operations | -44.66 | -15.10 | 5.71 | 9.33 | -20.58 |
| Earnings from Discontinued Operations | 3.00K | 850.00K | 826.00K | 2.68M | 393.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -44.65M | -14.25M | 6.54M | 12.01M | -20.19M |
| EBIT | -10.05M | -7.88M | -7.65M | -5.98M | -15.49M |
| EBITDA | -2.18M | -81.00K | -130.00K | 1.72M | -7.38M |
| EPS Basic | -1.48 | -0.50 | 0.22 | 0.39 | -0.68 |
| Normalized Basic EPS | -0.66 | -0.20 | 0.21 | 0.25 | 0.12 |
| EPS Diluted | -1.49 | -0.59 | 0.05 | 0.23 | -0.84 |
| Normalized Diluted EPS | -0.66 | -0.25 | 0.11 | 0.15 | 0.01 |
| Average Basic Shares Outstanding | 132.78M | 126.25M | 122.35M | 121.90M | 121.31M |
| Average Diluted Shares Outstanding | 132.78M | 132.37M | 134.43M | 133.98M | 133.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |